5 completed, 1 terminated, 1 unknown. 7 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 5, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Disseminated Neuroblastoma: new trials by email Literature Review of Disseminated Neuroblastoma trials Research Report on Disseminated Neuroblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma IL-2, GD2Bi-aATC, GM-CSF - Disseminated Neuroblastoma, Recurrent Neuroblastoma | Phase 1 / Phase 2 | Unknown | University of Virginia | 40 | 2014-11-01 | 2019-01-29 |
| Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia cefepime hydrochloride - Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia | Phase 1 | Completed | Wake Forest University Health Sciences | 70 | 2011-02-01 | 2018-07-18 |
| Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors tanespimycin, pharmacological study, laboratory biomarker analysis - Childhood Chronic Myelogenous Leukemia, Childhood Desmoplastic Small Round Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 70 | 2004-09-01 | 2013-06-04 |
| Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer ipilimumab, therapeutic allogeneic lymphocytes - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Phase 1 | Completed | National Cancer Institute (NCI) | 21 | 2003-04-01 | 2013-03-27 |
| Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma pyrazoloacridine, filgrastim, autologous bone marrow transplantation - Disseminated Neuroblastoma, Recurrent Neuroblastoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 42 | 2002-12-01 | 2013-04-09 |
| R(+)XK469 in Treating Patients With Advanced Neuroblastoma R(+)XK469 - Disseminated Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 1 | Completed | National Cancer Institute (NCI) | 85 | 2001-12-01 | 2013-12-16 |
| Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma monoclonal antibody Ch14.18, isotretinoin, aldesleukin - Disseminated Neuroblastoma, Recurrent Neuroblastoma | Phase 1 | Completed | National Cancer Institute (NCI) | 6 | 2001-01-01 | 2013-01-16 |
Neuroblastoma (6) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Breast Neoplasms (2) · Burkitt Lymphoma (2) · Carcinoma, Ovarian Epithelial (2) · Hodgkin Disease (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Immunoblastic (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, Non-Hodgkin (2)
Neoplasms by Histologic Type (7) · Neoplasms, Glandular and Epithelial (7) · Neoplasms (6) · Neoplasms, Germ Cell and Embryonal (6) · Neoplasms, Nerve Tissue (6) · Neoplasms, Neuroepithelial (6) · Neuroectodermal Tumors (6) · Neuroectodermal Tumors, Primitive (6) · Neuroectodermal Tumors, Primitive, Peripheral (5) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Leukemia (3) · Leukemia, Lymphoid (3)
Granulocyte-Macrophage Colony-Stimulating Factor (2) · Interleukin-2 (2) · aldesleukin (2) · sargramostim (2) · Bone Marrow Transplantation (1) · CTLA-4 Antigen (1) · Cefepime (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Ipilimumab (1) · Isotretinoin (1) · NSC 366140 (1) · Peripheral Blood Stem Cell Transplantation (1) · Transplantation (1) · XK 469 (1)
National Cancer Institute (NCI) (5) · University of Virginia (1) · Wake Forest University Health Sciences (1)
United States (7)
Andrew Gilman (1) · Anna Butturini (1) · Ewa Carrier (1) · John Williamson (1) · Maxim Yankelevich (1) · Susan Cohn (1) · Tanya Trippett (1)
P01CA081403 (1), P30CA022453 (1), R01CA093891 (1), U01CA069852 (1), U01CA069856 (1)